BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...Lilly Asia Ventures also participated in the round. Cancer company Ionova raises $17M series A Ionova Life Science Co. Ltd....
...Val Kennedy, Associate Editor Ascentage Pharma Group International dMed Biopharmaceutical Co. Ltd. ProQR Therapeutics N.V. Principia Biopharma Inc. Rhythm Pharmaceuticals Inc. Ionova Life Science Co. Ltd. INV-1120...
Items per page:
1 - 1 of 1
BioCentury | Oct 17, 2019
Financial News

Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

...Lilly Asia Ventures also participated in the round. Cancer company Ionova raises $17M series A Ionova Life Science Co. Ltd....
...Val Kennedy, Associate Editor Ascentage Pharma Group International dMed Biopharmaceutical Co. Ltd. ProQR Therapeutics N.V. Principia Biopharma Inc. Rhythm Pharmaceuticals Inc. Ionova Life Science Co. Ltd. INV-1120...
Items per page:
1 - 1 of 1